Neumora Therapeutics logo
Neumora Therapeutics
NMRA | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.01 (-2.64%)
At close: Nov 9, 2026, 4:00 PM ET

Neumora Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
-236.93M -243.79M -235.93M -130.9M -237.31M -99.27M
208K 631K 668K 594K 538K 105K
29.88M 39.99M 17.24M 8.3M 4.27M 1.68M
-508K 19.76M -8.32M -5.7M -202K 1.55M
841K -1.78M 63.64M 14.06M 158.09M 70.77M
– – – – -53K 3.08M
-437K 22.64M -8.9M -6.95M -961K -3.12M
-206.44M -182.94M -163.28M -114.9M -75.42M -26.76M
– – -117K -511K -817K -1.3M
– -775K – – – –
-85.8M -312.22M -109.07M -226.37M – –
251.17M 242.44M 178.17M 71.87M – –
3.15M – -4.59M -13M – -9.94M
168.52M -70.56M 64.39M -168.01M -817K -11.24M
57.16M – – – – 55.91M
– – -491K – – -2K
– – – – – –
– 7.91M -948K 3.53M 1.37M –
77.09M 21.6M 231.94M 115.74M 293.51M 230.1M
39.17M -231.89M 133.05M -167.17M 217.27M 192.1M
-206.44M -182.94M -163.4M -115.41M -76.24M -28.06M
-236.32M -222.93M -180.64M -123.71M -80.51M -29.74M
– – -117K -511K -538K -105K
– – – – -279K -1.2M
-206.44M -182.94M -163.4M -115.41M -75.96M -26.87M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.